Spine Conditions

Resource Center

Slideshows

Research Summaries

FDA Approval

FDA Approval

FDA Approves Isembyld as First Spinal Muscular Atrophy Therapy Targeting Muscle Loss

09/15/2026

Anthony Calabro, MA

A 52-week trial evaluated apitegromab-mstn as an adjunct to SMN2-targeted treatment in patients with spinal muscular atrophy who could not move or walk independently, demonstrating improved motor function...

09/15/2026

Research Summary

Research Summary

Reoperation Risk After Single-Level Lumbar Discectomy

10/06/2025

Anthony Calabro, MA

A large database analysis shows that nearly 15% of patients required additional lumbar surgery within 5 years of a single-level discectomy, with even higher risks after revision procedures.

10/06/2025

Research Summary

Research Summary

RECK Cocktail Reduces Pain, Opioid Use, and Hospital Stay After Posterior Spinal Fusion

09/05/2025

Kate Young

In a single-center retrospective cohort study, patients who received the RECK (ropivacaine-epinephrine-clonidine-ketorolac) cocktail during posterior spinal fusion experienced significantly lower...

09/05/2025

Research Summary

Research Summary

Does Semaglutide Influence Surgical Outcomes and Costs Following Posterior Cervical Fusion?

09/04/2025

Anthony Calabro, MA

In a large retrospective study, semaglutide users undergoing posterior cervical fusion had higher risks of pseudoarthrosis and dysphagia at 2 years. However, perioperative costs were significantly lower...

09/04/2025

Research Summary

Research Summary

Liberal Ambulation After Lumbar Fusion Linked to Shorter Stays, Fewer Complications

09/03/2025

Kate Young

In a retrospective cohort study, patients undergoing lumbar fusion who followed liberal ambulation protocols experienced shorter hospital stays, fewer complications, and were more likely to return home...

09/03/2025

October 2026

Current Issue

October 2026